Healthy Returns: The first drug for a common, deadly liver disease is here

Indonesia Berita Berita

Healthy Returns: The first drug for a common, deadly liver disease is here
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NBCLA
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 59%

Drugmakers are racing to catch up to Madrigal Pharmaceuticals, which has the first drug for NASH liver disease. Meanwhile, AI takes center stage at HIMSS.

MASH is a serious form of liver disease characterized by excess fat buildup and inflammation. It can lead to liver scarring and in more severe cases, liver failure or cancer. The condition is often associated with other health problems, such as high blood pressure, Type 2 diabetes and obesity.The agency's approval is also a big deal because it means Madrigal has succeeded in an area where several other drugmakers haveacross the U.S., France, Germany, Italy, Spain, the U.K.

"The absence of liver biopsy requirement in Rezdiffra's label should buoy biotech stocks" of companies developing MASH treatments and"potentially accelerate and broaden patient access," William Blair analyst Andy Hsieh wrote in a note Friday.In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen.But the question for all of those companies is how much a blockbuster class of drugs called GLP-1s will dominate the MASH market.

We'll likely have a better idea of what the MASH drug landscape will look like over the next year – and how big a threat GLP-1s will be – so stay tuned for our coverage!Perhaps unsurprisingly, generative artificial intelligence dominated my conversations at the HIMSS conference in Orlando, Florida last week.and more, the topic was quite literally hard to avoid.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NBCLA /  🏆 319. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Healthy Returns: What's next in the legal fight over Medicare drug price negotiationsHealthy Returns: What's next in the legal fight over Medicare drug price negotiationsThe legal battle over Medicare drug price negotiations is so far looking favorable for the Biden administration. Meanwhile, CNBC is on the ground at HIMSS!
Baca lebih lajut »

Health & FitnessHealth & FitnessFrom weight training to healthy exercise programs, find health and fitness information for a healthy lifestyle.
Baca lebih lajut »

Food & RecipesFood & RecipesHealthy recipes for healthy meals, find thousands of delicious recipes.
Baca lebih lajut »

Former Cubs right fielder Sammy Sosa returns to Chicago for first time in yearsFormer Cubs right fielder Sammy Sosa returns to Chicago for first time in yearsCubs legend Sammy Sosa returns to Chicago for first time in years
Baca lebih lajut »

These Higher-Protein Cookies Are Healthy Enough To Eat For BreakfastThese Higher-Protein Cookies Are Healthy Enough To Eat For BreakfastBreakfast cookies, anyone?
Baca lebih lajut »

These 5 Supplements Can Keep Your Skin Healthy and GlowingThese 5 Supplements Can Keep Your Skin Healthy and GlowingHere are the best skin supplements to improve your skin's overall health and appearance. Learn about the benefits and how to achieve glowing, healthy skin.
Baca lebih lajut »



Render Time: 2025-02-25 20:42:39